- In October 2024, Johnson & Johnson MedTech has introduced the ECHELON ENDOPATH™ Staple Line Reinforcement (SLR), a device designed to enhance staple line strength and minimize complications during bariatric, thoracic, and general surgeries. This innovation will help the company expand its product offerings in the surgical device market and strengthen its position in the bariatric and broader surgical segments by improving patient outcomes and increasing adoption among healthcare providers
- In July 2024, EziSurg's products have gained international recognition, appearing in markets such as France, Italy, the Middle East, and the United States, highlighting the strong performance of Chinese medical device brands globally. This widespread market presence will help the company expand its brand recognition, drive growth in international sales, and strengthen its competitive position in the global medical device industry
- In April 2024, Allurion Technologies, Inc. has announced the U.S. commercial launch of its Virtual Care Suite (VCS), a comprehensive tool designed to support obesity treatment. This move will help the company strengthen its presence in the digital health space, offering patients and healthcare providers a seamless, integrated solution that enhances the patient experience and treatment effectiveness, thus driving adoption and expanding its market share in the growing obesity care sector
